[Federal Register Volume 79, Number 82 (Tuesday, April 29, 2014)]
[Rules and Regulations]
[Pages 23914-23916]
[FR Doc No: 2014-09722]

-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Coast Guard

33 CFR Part 165

[Docket No. USCG-2014-0174]
RIN 1625-AA00

Safety Zone: Giants Enterprises Fireworks Display, San Francisco
Bay, San Francisco, CA

AGENCY: Coast Guard, DHS.

ACTION: Temporary final rule.

-----------------------------------------------------------------------

SUMMARY: The Coast Guard is establishing a temporary safety zone in the
navigable waters of the San Francisco Bay near AT&T Park in support of
Giants Enterprises Fireworks Display on May 21, 2014. This safety zone
is established to ensure the safety of participants and spectators from
the dangers associated with pyrotechnics. Unauthorized persons or
vessels are prohibited from entering into, transiting through, or
remaining in the safety zone without permission of the Captain of the
Port or his designated representative.

DATES: This rule is effective on May 21, 2014. This rule will be
enforced from 11 a.m. to 11 p.m. on May 21, 2014.

ADDRESSES: Documents mentioned in this preamble are part of docket
USCG-2014-0174. To view documents mentioned in this preamble as being
available in the docket, go to http://www.regulations.gov, type the
docket number in the ``SEARCH'' box and click ``SEARCH.'' Click on Open
Docket Folder on the line associated with this rulemaking. You may also
visit the Docket Management Facility in Room W12-140 on the ground
floor of the Department of Transportation West Building, 1200 New
Jersey Avenue SE., Washington, DC 20590, between 9 a.m. and 5 p.m.,
Monday through Friday, except Federal holidays.

FOR FURTHER INFORMATION CONTACT: If you have questions on this rule,
call or email Lieutenant Junior Grade William J. Hawn, U.S. Coast Guard
Sector San Francisco; telephone<PHONE_NUMBER> or email at<EMAIL_ADDRESS>If you have questions on viewing or submitting
material to the docket, call Barbara Hairston, Program Manager, Docket
Operations, telephone<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

Table of Acronyms

DHS Department of Homeland Security
FR Federal Register
NPRM Notice of Proposed Rulemaking

A. Regulatory History and Information

    The Coast Guard is issuing this temporary final rule without prior
notice and opportunity to comment pursuant to authority under section
4(a) of the Administrative Procedure Act (APA) (5 U.S.C. 553(b)). This
provision authorizes an agency to issue a rule without prior notice and
opportunity to comment when the agency for good cause finds that those
procedures are ``impracticable, unnecessary, or contrary to the public
interest.''
    Under 5 U.S.C. 553(d)(3), the Coast Guard finds that good cause
exists for making this rule effective less than 30 days after
publication in the Federal Register. The Coast Guard received the
information about the fireworks display on March 7, 2014, and the
fireworks display would occur before the rulemaking process would be
completed. Because of the dangers posed by the pyrotechnics used in
this fireworks display, the safety zone is necessary to provide for the
safety of event participants, spectators, spectator craft, and other
vessels transiting the event area. For the safety concerns noted, it is
in the public interest to have these regulations in effect during the
event.

B. Basis and Purpose

    The legal basis for the proposed rule is 33 U.S.C 1231; 46 U.S.C
Chapter 701, 3306, 3703; 50 U.S.C. 191, 195; 33 CFR 1.05-1, 6.04-1,
6.04-6, 160.5; Public Law 107-295, 116 Stat. 2064; Department of
Homeland Security Delegation No. 0170.1, which collectively authorize
the Coast Guard to establish safety zones.
    Giants Enterprises will sponsor the Giants Enterprises Fireworks
Display on May 21, 2014, near Pier 48 in San Francisco, CA in
approximate position 37[deg]46'40'' N, 122[deg]22'58'' W (NAD83) as
depicted in National Oceanic and Atmospheric Administration (NOAA)
Chart 18650. This safety zone establishes a temporary restricted area
on the waters 100 feet surrounding the fireworks barge during the
loading, transit and arrival of the pyrotechnics from the loading site
to the launch site and until the commencement of the fireworks display.
Upon the commencement of the fireworks display, the safety zone will
increase in size and encompass the navigable waters around the
fireworks barge within a radius of 700 feet. The fireworks display is
meant for entertainment purposes. This restricted area around the
fireworks barge is necessary to protect spectators, vessels, and other
property from the hazards associated with pyrotechnics.

C. Discussion of the Final Rule

    The Coast Guard will enforce a safety zone in navigable waters
around and under a fireworks barge within a radius of 100 feet during
the loading, transit, and arrival of the fireworks barge to the display
location and until the start of the fireworks display. From 11 a.m.
until 10 p.m. on May 21, 2014, the fireworks barge will be loading
pyrotechnics at Pier 50 in San Francisco, CA. From 10 p.m. to 10:10
p.m. on May 21, 2014 the loaded fireworks barge will transit from Pier
50 to the launch site near Pier 48 in approximate position
37[deg]46'40'' N, 122[deg]22'58'' W (NAD 83) where it will remain until
the commencement of the fireworks display. Upon the commencement of the
10-minute fireworks display, scheduled to begin at 10:50 p.m. on May
21, 2014, the safety zone will increase in size and encompass the
navigable waters around and under the fireworks barge within a radius
of 700 feet in approximate position 37[deg]46'40'' N, 122[deg]22'58'' W
(NAD 83) for the Giants Enterprises Fireworks Display. At the
conclusion of the fireworks display the safety zone shall terminate.
    The effect of the temporary safety zone will be to restrict
navigation in the vicinity of the launch site until the conclusion of
the scheduled display. Except for persons or vessels authorized by the
Coast Guard Patrol Commander, no person or vessel may enter or remain
in the restricted area. These regulations are needed to keep spectators
and vessels away from the immediate vicinity of the launch site to
ensure the safety of participants, spectators, and transiting vessels.

D. Regulatory Analyses

    We developed this rule after considering numerous statutes and
executive orders related to rulemaking. Below we summarize our analyses
based on these statutes and executive orders.

1. Regulatory Planning and Review

    This rule is not a significant regulatory action under section 3(f)
of Executive Order 12866, Regulatory Planning and Review, as
supplemented by Executive Order 13563, Improving Regulation and
Regulatory Review, and does not require an assessment of potential
costs and benefits under section 6(a)(3) of Executive Order 12866 or
under section 1 of Executive Order 13563. The Office of Management and
Budget has not reviewed it under those Orders.
    We expect the economic impact of this rule will not rise to the
level of necessitating a full Regulatory Evaluation. The safety zone is
limited in duration, and is limited to a narrowly tailored geographic
area. In addition, although this rule restricts access to the waters
encompassed by the safety zone, the effect of this rule will not be
significant because the local waterway users will be notified via
public Broadcast Notice to Mariners to ensure the safety zone will
result in minimum impact. The entities most likely to be affected are
waterfront facilities, commercial vessels, and pleasure craft engaged
in recreational activities.

2. Impact on Small Entities

    The Regulatory Flexibility Act of 1980 (RFA), 5 U.S.C. 601-612, as
amended, requires federal agencies to consider the potential impact of
regulations on small entities during rulemaking. The term ``small
entities'' comprises small businesses, not-for-profit organizations
that are independently owned and operated and are not dominant in their
fields, and governmental jurisdictions with populations of less than
50,000.
    This rule may affect owners and operators of waterfront facilities,
commercial vessels, and pleasure craft engaged in recreational
activities and sightseeing. This safety zone would not have a
significant economic impact on a substantial number of small entities
for the following reasons. This safety zone would be activated, and
thus subject to enforcement, for a limited duration. When the safety
zone is activated, vessel traffic could pass safely around the safety
zone. The maritime public will be advised in advance of this safety
zone via Broadcast Notice to Mariners.

3. Assistance for Small Entities

    Under section 213(a) of the Small Business Regulatory Enforcement
Fairness Act of 1996 (Pub. L. 104-121), we want to assist small
entities in understanding this rule. If the rule would affect your
small business, organization, or governmental jurisdiction and you have
questions concerning its provisions or options for compliance, please
contact the person listed in the FOR FURTHER INFORMATION CONTACT,
above.
    Small businesses may send comments on the actions of Federal
employees who enforce, or otherwise determine compliance with, Federal
regulations to the Small Business and Agriculture Regulatory
Enforcement Ombudsman and the Regional Small Business Regulatory
Fairness Boards. The Ombudsman evaluates these actions annually and
rates each agency's responsiveness to small business. If you wish to
comment on actions by employees of the Coast Guard, call 1-888-REG-FAIR
(1-888-734-3247). The Coast Guard will not retaliate against small
entities that question or complain about this rule or any policy or
action of the Coast Guard.

4. Collection of Information

    This rule will not call for a new collection of information under
the Paperwork Reduction Act of 1995 (44 U.S.C. 3501-3520).

5. Federalism

    A rule has implications for federalism under Executive Order 13132,
Federalism, if it has a substantial direct effect on the States, on the
relationship between the national government and the States, or on the
distribution of power and responsibilities among the various levels of
government. We have analyzed this rule under that Order and determined
that this rule does not have implications for federalism.

6. Protest Activities

    The Coast Guard respects the First Amendment rights of protesters.
Protesters are asked to contact the person listed in the FOR FURTHER
INFORMATION CONTACT section to coordinate protest activities so that
your message can be received without jeopardizing the safety or
security of people, places or vessels.

7. Unfunded Mandates Reform Act

    The Unfunded Mandates Reform Act of 1995 (2 U.S.C. 1531-1538)
requires Federal agencies to assess the effects of their discretionary
regulatory actions. In particular, the Act addresses actions that may
result in the expenditure by a State, local, or tribal government, in
the aggregate, or by the private sector of $100,000,000 (adjusted for
inflation) or more in any one year. Though this rule will not result in
such an expenditure, we do discuss the effects of this rule elsewhere
in this preamble.

8. Taking of Private Property

    This rule will not cause a taking of private property or otherwise
have taking implications under Executive Order 12630, Governmental
Actions and Interference with Constitutionally Protected Property
Rights.

9. Civil Justice Reform

    This rule meets applicable standards in sections 3(a) and 3(b)(2)
of Executive Order 12988, Civil Justice Reform, to minimize litigation,
eliminate ambiguity, and reduce burden.

10. Protection of Children

    We have analyzed this rule under Executive Order 13045, Protection
of Children from Environmental Health Risks and Safety Risks. This rule
is not an economically significant rule and does not create an
environmental risk to health or risk to safety that may
disproportionately affect children.

11. Indian Tribal Governments

    This rule does not have tribal implications under Executive Order
13175, Consultation and Coordination with Indian Tribal Governments,
because it does not have a substantial direct effect on one or more
Indian tribes, on the relationship between the Federal Government and
Indian tribes, or on the distribution of power and responsibilities
between the Federal Government and Indian tribes.

12. Energy Effects

    This action is not a ``significant energy action'' under Executive
Order 13211, Actions Concerning Regulations That Significantly Affect
Energy Supply, Distribution, or Use.

13. Technical Standards

    This rule does not use technical standards. Therefore, we did not
consider the use of voluntary consensus standards.

14. Environment

    We have analyzed this rule under Department of Homeland Security
Management Directive 023-01 and Commandant Instruction M16475.lD, which
guide the Coast Guard in complying with the National Environmental
Policy Act of 1969 (NEPA) (42 U.S.C. 4321-4370f), and have determined
that this action is one of a category of actions that do not
individually or cumulatively have a significant effect on the human
environment. This rule involves a safety zone of limited size and
duration. This rule is categorically excluded from further review under
paragraph 34(g) of Figure 2-1 of the Commandant

Instruction. An environmental analysis checklist supporting this
determination and a Categorical Exclusion Determination are available
in the docket where indicated under ADDRESSES. We seek any comments or
information that may lead to the discovery of a significant
environmental impact from this rule.

List of Subjects in 33 CFR Part 165

    Harbors, Marine safety, Navigation (water), Reporting and
recordkeeping requirements, Security measures, and Waterways.

    For the reasons discussed in the preamble, the Coast Guard amends
33 CFR Part 165 as follows:

PART 165--REGULATED NAVIGATION AREAS AND LIMITED ACCESS AREAS

0
1. The authority citation for part 165 continues to read as follows:

    Authority: 33 U.S.C. 1231; 46 U.S.C. Chapter 701, 3306, 3707; 50
U.S.C. 191, 195; 33 CFR 1.05-1, 6.04-1, 6.04-6, 160.5; Pub. L. 107-
295, 116 Stat. 2064; Department of Homeland Security Delegation No.
0170.1.

0
2. Add temporary Sec.  165.T11-630 to read as follows:

Sec.  165.T11-630  Safety zone; Giants Enterprises Fireworks Display,
San Francisco Bay, San Francisco, CA.

    (a) Location. This temporary safety zone is established in the
navigable waters of the San Francisco Bay near Pier 48 in San
Francisco, CA as depicted in National Oceanic and Atmospheric
Administration (NOAA) Chart 18650. From 11 a.m. until 10:50 p.m. on May
21, 2014, the temporary safety zone applies to the nearest point of the
fireworks barge within a radius of 100 feet during the loading,
transit, and arrival of the fireworks barge from Pier 50 to the launch
site near Pier 48 in approximate position 37[deg]46'40'' N,
122[deg]22'58'' W (NAD83). From 10:50 p.m. until 11 p.m. on May 21,
2014, the temporary safety zone will increase in size and encompass the
navigable waters around and under the fireworks barge in approximate
position 37[deg]46'40'' N, 122[deg]22'58'' W (NAD83) within a radius of
700 feet.
    (b) Enforcement Period. The zone described in paragraph (a) of this
section will be enforced from 11 a.m. through 11 p.m. on May 21, 2014.
The Captain of the Port San Francisco (COTP) will notify the maritime
community of periods during which this zone will be enforced via
Broadcast Notice to Mariners in accordance with 33 CFR 165.7.
    (c) Definitions. As used in this section, ``designated
representative'' means a Coast Guard Patrol Commander, including a
Coast Guard coxswain, petty officer, or other officer on a Coast Guard
vessel or a Federal, State, or local officer designated by or assisting
the COTP in the enforcement of the safety zone.
    (d) Regulations. (1) Under the general regulations in 33 CFR Part
165, Subpart C, entry into, transiting or anchoring within this safety
zone is prohibited unless authorized by the COTP or a designated
representative.
    (2) The safety zone is closed to all vessel traffic, except as may
be permitted by the COTP or a designated representative.
    (3) Vessel operators desiring to enter or operate within the safety
zone must contact the COTP or a designated representative to obtain
permission to do so. Vessel operators given permission to enter or
operate in the safety zone must comply with all directions given to
them by the COTP or a designated representative. Persons and vessels
may request permission to enter the safety zone on VHF-23A or through
the 24-hour Command Center at telephone<PHONE_NUMBER>.

    Dated: April 11, 2014.
Gregory G. Stump,
Captain, U.S. Coast Guard, Captain of the Port San Francisco.
[FR Doc. 2014-09722 Filed 4-28-14; 8:45 am]
BILLING CODE 9110-04-P


From:	"Frey, Nathan J."<EMAIL_ADDRESS>To:	Lydia Wegman/RTP/USEPA/US@EPA
Date:	06/14/2012 06:06 PM
Subject:	RE: One more edit to the Executive Summary--please review this version

Attached for your consideration please find a summary of additional interagency comments under EOs 12866 and 13563 regarding the executive summary portion of the preamble.

From: Lydia Wegman<EMAIL_ADDRESS>Sent: Thursday, June 14, 2012 5:39 PM
To: Frey, Nathan J.; Mancini, Dominic J.
Cc: Beth Hassett-Sipple<EMAIL_ADDRESS><EMAIL_ADDRESS>Joseph-J Dougherty; Janet McCabe; Gina McCarthy
Subject: One more edit to the Executive Summary--please review this version

Nathan and Dom,

I realized that there was one edit we failed to include in the last version I sent you of the Executive Summary related to spatial averaging. Please review this version of the revisions. Thanks.
(See attached file: Executive Summary 06 14 12 534 pm compare to 05 29 12.docx)

   I.          Executive Summary
       A. Purpose of this Regulatory Action
      Sections 108 and 109 of the Clean Air Act (CAA) govern the establishment, review, and revision, as appropriate, of the national ambient air quality standards (NAAQS) to protect public health and welfare. The CAA requires periodic review of the air quality criteria  -  the science upon which the standards are based  -  and the standards themselves. This proposed rulemaking is being done pursuant to a court order and these statutory requirements.
      In this proposed rule, we discuss EPA's current perspectives on implementation issues related to the proposed revisions to the PM NAAQS. The EPA proposes revisions to the Prevention of Significant Deterioration (PSD) permitting regulations to address the proposed changes in the primary and secondary PM NAAQS. The EPA also proposes an approach for implementing the PSD program specifically for the proposed secondary standard.
      In 2006, the EPA completed the last review of the PM NAAQS. In that review, it undertook three principal actions. (1) With regard to fine particles (generally referring to particles less than or equal to 2.5 micrometers (um) in diameter, PM2.5), the EPA revised the level of the primary 24-hour PM2.5 standard from 65 to 35 ug/m[3] and retained the level of the primary annual PM2.5 standard. (2) With regard to the primary standards for particles less than or equal to 10 um in diameter (PM10), the EPA retained the primary 24-hour PM10 standard to continue to provide protection against effects associated with short-term exposure to thoracic coarse particles (i.e., PM10-2.5) and revoked the primary annual PM10 standard. (3) The EPA  revised the secondary standards to be identical in all respects to the primary standards.
      In subsequent litigation, the U.S. Court of Appeals for the District of Columbia Circuit remanded the primary annual PM2.5 standard to EPA on the ground that EPA failed to explain adequately why the standard provided the requisite protection from both short- and long-term exposures to fine particles, including protection for at-risk populations such as children. The Court also remanded the secondary PM2.5 standards to the EPA on the ground that the Agency failed to explain adequately why setting the secondary standards identical to the primary standards provided the required protection for public welfare, including protection from PM-related visibility impairment. The EPA is responding to the court's remands as part of the current review of the PM NAAQS.
      This review was initiated in June 2007. Between 2007 and 2011, EPA prepared draft and final Integrated Science Assessments, Risk and Exposure Assessments, and Policy Assessments.  Multiple drafts of all of these documents were subject to review by the public and peer reviewed by EPA's Clean Air Scientific Advisory Committee. This proposed rulemaking is the next step in the review process; as noted, the schedule for this rulemaking is subject to a court order requiring issuance of a proposed rule at this time.
      In this rulemaking, the EPA proposes to make revisions to the suite of primary and secondary standards for PM to provide increased protection of public health and welfare
      . We also discuss EPA's current perspectives on implementation issues related to the proposed revisions to the PM NAAQS. The EPA proposes revisions to the Prevention of Significant Deterioration (PSD) permitting regulations to address the proposed changes in the primary and secondary PM NAAQS as well as corresponding changes to ambient air monitoring, reporting and network design requirements The EPA also proposes an approach for implementing the PSD program specifically for the proposed secondary standard.
       B. Summary of Major Provisions
      With regard to the primary standards for fine particles, EPA proposes to revise the annual PM2.5 standard by lowering the level from 15.0 to within a range of 12.0 to 13.0 ug/m[3] so as to provide increased protection against health effects associated with long- and short-term exposures. The EPA proposes to retain the level (35 ug/m[3]) and the form (98[th] percentile) of the 24-hour PM2.5 standard to provide supplemental protection against health effects associated with short-term exposures. This proposed action would provide increased protection for children, older adults, persons with pre-existing heart and lung disease, and other at-risk populations against an array of PM2.5-related adverse health effects that include premature mortality, increased hospital admissions and emergency department visits, and development of chronic respiratory disease. The EPA also proposes to eliminate spatial averaging provisions as part of the form of the annual standard to avoid potential disproportionate impacts on at-risk populations.
      The proposed changes to the primary annual PM2.5 standard are within the range that the Clean Air Scientific Advisory Committee advised the Agency to consider. These changes are based on an integrative assessment of an extensive body of new scientific evidence, which substantially strengthens what was known about PM2.5-related health effects in the last review, including extended analyses of key epidemiological studies, and evidence of   health effects observed at lower ambient PM2.5 concentrations, , including  effects in areas that likely met the current standards. The proposed changes also reflect consideration of a quantitative risk assessment that estimates public health risks likely to remain upon just meeting the current and various alternative standards. Based on this information, the Administrator proposes to conclude that the current primary PM2.5 standards are not requisite to protect public health with an adequate margin of safety, as required by the CAA, and that the proposed revisions are warranted to provide the appropriate degree of increased public health protection. The EPA solicits comment on all aspects of the proposed primary PM2.5 standards.

      With regard to the primary standard for coarse particles, EPA proposes to retain the current 24-hour PM10 standard, with a level of 150 ug/m[3] and a one-expected exceedance form, to continue to provide protection against effects associated with short-term exposure to PM10-2.5, including premature mortality and increased hospital admissions and emergency department visits. In reaching this decision, the Administrator proposes to conclude that the available health evidence and air quality information for PM10-2.5, taken together with the considerable uncertainties and limitations associated with that information, suggests that the degree of public health protection provided against short-term exposures to PM10-2.5 does not need to be increased beyond that provided by the current PM10 standard. The Administrator welcomes the public's views on these approaches to considering and accounting for the evidence and its limitations and uncertainties.
      With regard to the secondary PM standards, the EPA proposes to revise the suite of secondary PM standards by adding a distinct standard for PM2.5 to address PM-related visibility impairment. More specifically, the EPA proposes to establish a secondary standard defined in terms of a PM2.5 visibility index, which would use speciated PM2.5 mass concentrations and relative humidity data to calculate PM2.5 light extinction, similar to the Regional Haze Program; a 24-hour averaging time; a 90[th] percentile form, averaged over 3 years; and a level set at one of two options  -  either 30 deciviews (dv) or 28 dv. The EPA also proposes to rely upon the existing Chemical Speciation Network (CSN) to provide appropriate monitoring data for calculating PM2.5 visibility index values.
      The proposed secondary standard is based on the long-standing science characterizing the contribution of PM, especially fine particles, to visibility impairment and on air quality analyses, with consideration also given to a reanalysis of public perception surveys regarding people's stated preferences regarding acceptable and unacceptable visual air quality. Based on this information, the Administrator proposes to conclude that the current secondary PM2.5 standards are not sufficiently protective of the public welfare with respect to visual air quality. The EPA solicits comment on all aspects of the proposed secondary standard.
      To address other non-visibility welfare effects including ecological effects, effects on materials, and climate impacts, the EPA proposes to retain the current suite of secondary PM standards generally, while proposing to revise only the form of the secondary annual PM2.5 standard to remove the option for spatial averaging consistent with this proposed change to the primary annual PM2.5 standard.
      The proposed revisions to the PM NAAQS would trigger a process under which states (and tribes, if they choose) will make recommendations to the Administrator regarding designations, identifying areas of the country that either meet or do not meet the proposed new or revised NAAQS for PM2.5. States will also review, modify and supplement their existing state implementation plans. The proposed NAAQS revisions would affect the applicable air permitting requirements and the transportation conformity and general conformity processes. This notice provides background information for understanding the implications of the proposed NAAQS revisions for these implementation processes and describes and requests comment on EPA's current perspectives on implementation issues. In addition, the EPA proposes to revise its PSD regulations to provide limited grandfathering from the requirements that result from the revised PM NAAQS for permit applications for which the public comment period has begun when the revised PM NAAQS take effect. The EPA also proposes to implement a surrogate approach that would provide a mechanism for permit applicants to demonstrate that they will not cause or contribute to a violation of the proposed secondary PM2.5 visibility index NAAQS. It is the EPA's intention to finalize any time-sensitive revisions to its PSD regulations at the same time as any new or revised NAAQS are finalized.
      With regard to implementation-related activities, the EPA intends to promulgate rules or develop guidance related to NAAQS implementation on a schedule that provides timely clarity to the states, tribes, and other parties responsible for NAAQS implementation. The EPA solicits comment on all implementation aspects during the public comment period for this notice and will consider these comments as it develops future rulemaking or guidance, as appropriate.
      On other topics, the EPA proposes changes to the Air Quality Index (AQI) for PM2.5 to be consistent with the proposed primary PM2.5 standards. The EPA also proposes revisions to the data handling procedures consistent with the proposed primary and secondary standards for PM2.5 including the computations necessary for determining when these standards are met and the measurement data that are appropriate for comparison to the standards. With regard to monitoring-related activities, the EPA proposes updates to several aspects of the monitoring regulations and specifically proposes to require that a small number of PM2.5 monitors be relocated to be collocated with measurements of other pollutants (e.g., nitrogen dioxide, carbon monoxide) in the near-road environment.
       C. Costs and Benefits
      In setting the NAAQS, the EPA may not consider the costs of implementing the standards. This was confirmed by the Supreme Court in Whitman v. American Trucking Associations, 531 U.S. 457, 465-472, 475-76 (2001), as discussed in section II.A of this notice. As has traditionally been done in NAAQS rulemaking, the EPA has conducted a Regulatory Impact Analysis (RIA) to provide the public with information on the potential costs and benefits of attaining several alternative PM2.5 standards. In NAAQS rulemaking, the RIA is done for informational purposes only, and the proposed decisions on the NAAQS in this rulemaking are not in any way based on consideration of the information or analyses in the RIA. The RIA fulfills the requirements of Executive Orders 13563 and 12866..
      The summary of the RIA, which is discussed in more detail below in section X.A., estimates benefits ranging from $88 million to $220 million (for 13.0 ug/m[3]) and from $2.3 billion to $5.9 billion per year (for 12.0 ug/m[3]) in 2020 and costs ranging from $2.9 million (for 13.0 ug/m[3]) to $69 million (for 12.0 ug/m[3]) per year.


[Federal Register Volume 79, Number 84 (Thursday, May 1, 2014)]
[Notices]
[Page 24702]
[FR Doc No: 2014-09973]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings 1

    Take notice that the Commission received the following electric
rate filings:

    Docket Numbers: ER14-480-001.
    Applicants: California Independent System Operator Corporation.
    Description: 2014-04-21 Compliance Filing in Docket No. ER14-480 to
be effective 5/1/2014.
    Filed Date: 4/21/14.
    Accession Number: 20140421-5221.
    Comments Due: 5 p.m. ET 5/12/14.

    Docket Numbers: ER14-1320-002.
    Applicants: Midcontinent Independent System Operator, Inc.
    Description: 2014-04-22--SA 2632 Northeast Power-ITC-AECI T-T 2nd
Amendment to be effective 1/29/2014.
    Filed Date: 4/22/14.
    Accession Number: 20140422-5127.
    Comments Due: 5 p.m. ET 5/13/14.

    Docket Numbers: ER14-1729-000.
    Applicants: California Independent System Operator Corporation.
    Description: 2012-04-22 Errata to Attachment C to NVE EIMIA Filing
to be effective N/A.
    Filed Date: 4/22/14.
    Accession Number: 20140422-5180.
    Comments Due: 5 p.m. ET 5/13/14.

    Docket Numbers: ER14-1750-000.
    Applicants: Consolidated Edison Company of New York, New York
Independent System Operator, Inc.
    Description: Con Edison NYPA restated OM Agreement No. 2013 to be
effective 4/23/2014.
    Filed Date: 4/22/14.
    Accession Number: 20140422-5264.
    Comments Due: 5 p.m. ET 5/13/14.

    Docket Numbers: ER14-1754-000.
    Applicants: Ameren Illinois Company.
    Description: Meter Replacement Letter Agreement Between AIC, IMEA,
and City of Casey to be effective 3/23/2014.
    Filed Date: 4/22/14.
    Accession Number: 20140422-5221.
    Comments Due: 5 p.m. ET 5/13/14.

    Docket Numbers: ER14-1755-000.
    Applicants: Lykins Energy Solutions.
    Description: MBR Application to be effective 5/23/201.
    Filed Date: 4/23/14.
    Accession Number: 20140423-5048.
    Comments Due: 5 p.m. ET 5/14/14.

    Docket Numbers: ER14-1756-000.
    Applicants: Southern California Edison Company.
    Description: GIA and Distribution Service Agreement with Aries
Solar Holding, LLC to be effective 4/24/2014.
    Filed Date: 4/23/14.
    Accession Number: 20140423-5107.
    Comments Due: 5 p.m. ET 5/14/14.

    Docket Numbers: ER14-1757-000.
    Applicants: ITC Midwest LLC.
    Description: Filing of Amended and Restated Facilities and
Operating Agreement to be effective 6/24/2014.
    Filed Date: 4/23/14.
    Accession Number: 20140423-5111.
    Comments Due: 5 p.m. ET 5/14/14.

    Docket Numbers: ER14-1758-000.
    Applicants: Appalachian Power Company.
    Description: Notice of Cancellation of Appalachian Power Company.
    Filed Date: 4/23/14.
    Accession Number: 20140423-5121.
    Comments Due: 5 p.m. ET 5/14/14.

    Docket Numbers: ER14-1759-000.
    Applicants: Appalachian Power Company.
    Description: Notice of Cancellation of Appalachian Power Company.
    Filed Date: 4/23/14.
    Accession Number: 20140423-5132.
    Comments Due: 5 p.m. ET 5/14/14.

    Docket Numbers: ER14-1760-000.
    Applicants: Midcontinent Independent System Operator, Inc.
    Description: 2014-04-23--SA 2659 Ameren-FutureGen Construction
Agreement to be effective 4/18/2014 under ER14-1760 Filing Type: 10.
    Filed Date: 4/23/14.
    Accession Number: 20140423-5164.
    Comments Due: 5 p.m. ET 5/14/14.

    Take notice that the Commission received the following electric
securities filings:

    Docket Numbers: ES14-37-000.
    Applicants: AEP Generating Company.
    Description: Application Under Section 204 of the Federal Power Act
for Authorization to Issue Securities of AEP Generating Company.
    Filed Date: 4/22/14.
    Accession Number: 20140422-5259.
    Comments Due: 5 p.m. ET 5/13/14.

    The filings are accessible in the Commission's eLibrary system by
clicking on the links or querying the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: April 23, 2014.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2014-09973 Filed 4-30-14; 8:45 am]
BILLING CODE 6717-01-P


MEMORANDUM

TO:	EPA-HQ-OAR-2021-0317

FROM:	Melissa Weitz, EPA

DATE:		April 27, 2022

SUBJECT:	Meeting with Zahroof Valves

On April 27, 2022, EPA met with Zahroof Valves to discuss compressor valves.

External Participants (invited): James Ilaria and Zahroof Zee from Zahroof Valves EPA (invited): Melissa Weitz, Sarah Menassian, Mark DeFiguerido, Karen Marsh, Amy Hambrick, Andy Sheppard, Suzie Waltzer, Stephanie Bogle, Siddhartha Patel

Attachments (1) 3/16/2022 Email from James Ilaria to Karen Marsh


[Federal Register Volume 88, Number 203 (Monday, October 23, 2023)]
[Notices]
[Pages 72767-72771]
[FR Doc No: 2023-23374]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2023-N-4468]

Animal Generic Drug User Fee Program Rates and Payment Procedures
for Fiscal Year 2024

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing
the fee rates and payment procedures for fiscal year (FY) 2024 generic
new animal drug program user fees. The Federal Food, Drug, and Cosmetic
Act (FD&C Act), as amended by the Animal Generic Drug User Fee
Amendments of 2023 (AGDUFA IV), authorizes FDA to collect user fees for
certain abbreviated applications for generic new animal drugs, for
certain generic new animal drug products, for certain sponsors of such
abbreviated applications for generic new animal drugs and/or
investigational submissions for generic new animal drugs, and for
certain submissions related to generic investigational new animal drug
(JINAD) files. This notice establishes the fee rates for FY 2024.

DATES: The application fee rates are effective for all abbreviated
applications for a generic new animal drug submitted on or after
October 1, 2023, and will remain in effect through September 30, 2024.
The fee rates for requests to establish a JINAD file, and for certain
submissions to JINAD files established prior to October 1, 2023, are
effective on October 1, 2023, and will remain in effect through
September 30, 2024.

FOR FURTHER INFORMATION CONTACT: Lisa Kable, Center for Veterinary
Medicine (HFV-10), Food and Drug Administration, 7500 Standish Pl.,
Rockville, MD 20855,<PHONE_NUMBER>, [email protected], or visit
FDA's website at https://www.fda.gov/ForIndustry/UserFees/AnimalGenericDrugUserFeeActAGDUFA/default.htm. For general questions,
you may also email the Center for Veterinary

Medicine (CVM) at [email protected].

SUPPLEMENTARY INFORMATION:

I. Background

    Section 741 of the FD&C Act (21 U.S.C. 379j-21) establishes four
different types of user fees: (1) fees for certain types of abbreviated
applications for generic new animal drugs; (2) annual fees for certain
generic new animal drug products; (3) annual fees for certain sponsors
of abbreviated applications for generic new animal drugs and/or
investigational submissions for generic new animal drugs; and (4) JINAD
file fees (21 U.S.C. 379j-21(a)). When certain conditions are met, FDA
will waive or reduce fees for generic new animal drugs intended solely
to provide for a minor use or minor species indication (21 U.S.C. 379j-
21(d)).
    For FYs 2024 through FY 2028, the FD&C Act establishes a base
revenue amount for each fiscal year (21 U.S.C. 379j-21(b)(1)). Base
revenue amounts established for fiscal years after FY 2024 are subject
to adjustment for inflation and workload. Workload increases will be
adjusted for excess collections after FY 2025 (21 U.S.C. 379j-21(c)).
Fees are to be established each year by FDA so that the percentage
allocations for each of the fee categories is as follows: 20 percent
shall be derived from fees for abbreviated applications for a generic
new animal drug and JINAD file fees; 40 percent shall be derived from
fees for generic new animal drug products; and 40 percent shall be
derived from fees for generic new animal drug sponsors (21 U.S.C. 379j-
21(b)). The target revenue amounts for each fee category for FY 2024,
are as follows: for application and/or JINAD file fees, the target
revenue amount is $5,000,000; for product fees, the target revenue
amount is $10,000,000; and for sponsor fees, the target revenue amount
is $10,000,000.
    For FY 2024, the AGDUFA rates are: $126,582 for each abbreviated
application for a generic new animal drug other than those subject to
the criteria in section 512(d)(4) of the FD&C Act (21 U.S.C.
360b(d)(4)); $63,291 for each abbreviated application for a generic new
animal drug subject to the criteria in section 512(d)(4) of the FD&C
Act; $50,000 for each JINAD file request or certain submissions to
established JINAD files; $16,393 for each generic new animal drug
product; $258,331 for each generic new animal drug sponsor paying 100
percent of the sponsor fee; $193,748 for each generic new animal drug
sponsor paying 75 percent of the sponsor fee; and $129,166 for each
generic new animal drug sponsor paying 50 percent of the sponsor fee.
FDA will issue invoices for FY 2024 product and sponsor fees by
December 31, 2023, and payment will be due by January 31, 2024. The
application fee rates are effective for all abbreviated applications
for a generic new animal drug submitted on or after October 1, 2023,
and will remain in effect through September 30, 2024. The fee rate for
requests to establish a JINAD file, and for certain submissions to
JINAD files established prior to October 1, 2023, is effective on
October 1, 2023, and will remain in effect through September 30, 2024.
    Applications will not be accepted for review until FDA has received
full payment of application fees and any other fees owed under the
AGDUFA program. Similarly, a request to establish a JINAD file will not
be accepted for action by FDA until FDA has received full payment of
all fees owed under the AGDUFA program. (21 U.S.C. 379j-21(e)).

II. Revenue Amount for FY 2024

A. Statutory Fee Revenue Amount

    AGDUFA IV, Title III of Public Law 118-15, specifies that the
aggregate base fee revenue amount for FY 2024 for all user fee
categories is $25,000,000 (21 U.S.C. 379j-21(b)(1)).

B. Inflation Adjustment to Fee Revenue Amount

    AGDUFA IV specifies that the annual fee revenue amount is to be
adjusted for inflation increases for FY 2025 and subsequent fiscal
years. (21 U.S.C. 379j-21(c)(2)). Since AGDUFA IV does not adjust for
inflation until FY 2025, there is no inflation adjustment for FY 2024.

C. Workload Adjustment to Inflation Adjusted Fee Revenue Amount

    The fee revenue amounts established in AGDUFA IV for FY 2025 and
subsequent fiscal years are also subject to adjustment to account for
changes in FDA's review workload (21 U.S.C. 379j-21(c)(3)(A)). Since
AGDUFA IV does not adjust for workload until FY 2025, there is no
workload adjustment for FY 2024.

D. FY 2024 Fee Revenue Amounts

    AGDUFA IV specifies that the revenue amount of $25,000,000 for FY
2024 is to be divided as follows: 20 percent, or a total of $5,000,000,
is to come from application and/or JINAD file fees; 40 percent, or a
total of $10,000,000, is to come from product fees; and 40 percent, or
a total of $10,000,000, is to come from sponsor fees (21 U.S.C. 379j-
21(b)).

III. Abbreviated Application Fee and JINAD File Fee Calculations for FY
2024

A. Fee Revenues and Numbers of Fee-Paying Applications and Submissions

    Each person who submits an abbreviated application for a generic
new animal drug shall be subject to an application fee, with limited
exceptions (21 U.S.C. 379j-21(a)(1)). The term ``abbreviated
application for a generic new animal drug'' means an abbreviated
application for the approval of any generic new animal drug submitted
under section 512(b)(2) of the FD&C Act. FDA will also assess fees
related to JINAD files. FDA will assess a fee under section
741(a)(4)(A)(i) of the FD&C Act when a person submits a request to
establish a new JINAD file. FDA will assess a fee under section
741(a)(4)(A)(ii) of the FD&C Act for a person's first submission, as
described below, to a JINAD file on or after October 1, 2023, where the
JINAD file had been established prior to that date. The JINAD file fee
is set in accordance with section 741(c)(1)(C) of the FD&C Act at
$50,000. FDA will set the abbreviated application fee so that such fees
combined with the JINAD file fees will generate a combined total of
$5,000,000 in fee revenue for FY 2024.
    To set fees for abbreviated applications for generic new animal
drugs, FDA must first make some assumptions about the number of fee-
paying abbreviated applications it will receive during FY 2024, the
number of requests to establish new JINAD files it will receive during
FY 2024, and the number of existing (prior to October 1, 2023) JINAD
files to which it will receive submissions during FY 2024.
    Regarding the fee for a person's first submission to an existing
(prior to October 1, 2023) JINAD file on or after October 1, 2023, FDA
intends to assess a fee only for the first data (or ``P'') submission
to the Bioequivalence (BE) or Chemistry, Manufacturing, and Controls
(CMC) technical sections of the JINAD file. The Agency has selected P
submissions to the BE or CMC technical sections as the basis for
assessing this fee because P submissions to these sections consistently
entail the substantial use of FDA review hours during the phased review
process.
    The Agency knows the numbers of applications and submissions that
have been submitted in previous years. Those numbers fluctuate
annually. In estimating the fee revenue to be generated by application
and submission fees in FY 2024, FDA is assuming that the number of
applications and submissions for which

fees will be paid in FY 2024 will equal the average number of
applications and submissions over the 5 most recently completed fiscal
years of the AGDUFA program (FY 2018 through FY 2022).
    Also, under AGDUFA IV an abbreviated application for a generic new
animal drug subject to the criteria in section 512(d)(4) of the FD&C
Act and submitted on or after October 1, 2013, shall be subject to 50
percent of the fee applicable to all other abbreviated applications for
a generic new animal drug (21 U.S.C. 379j-21(a)(1)(C)(ii)).
    The average number of original submissions of abbreviated
applications for generic new animal drugs over the 5 most recently
completed fiscal years is 12.6 applications not subject to the criteria
in section 512(d)(4) of the FD&C Act and 6.4 submissions subject to the
criteria in section 512(d)(4). Each of the submissions described under
section 512(d)(4) of the FD&C Act pays 50 percent of the fee paid by
the other applications and will be counted as one half of a fee. Adding
all of the applications not subject to the criteria in section
512(d)(4) of the FD&C Act and 50 percent of the number that are subject
to such criteria results in a total of 15.80 anticipated full fees.
    Based on the previous assumptions, FDA is estimating that it will
receive a total of 15.80 fee-paying generic new animal drug
applications in FY 2024 (12.6 original applications paying a full fee
and 6.4 applications paying a half fee).
    For estimating the number of requests to establish a new JINAD file
and the number of P submissions to the BE or CMC section of an existing
(prior to October 1, 2023) JINAD file the Agency will receive in FY
2024, FDA took the average annual number of new JINAD file requests and
P submissions to the BE or CMC section of an existing JINAD file
received over the last 5 completed fiscal years. The average annual
number of requests to establish new JINAD files and P submissions to
the BE or CMC section of existing JINAD files over the 5 most recently
completed fiscal years is 60.
    Based on the previous assumptions, FDA is estimating that it will
receive a total of 60 fee-paying JINAD file submissions in FY 2024
(including both requests to establish new JINAD files and first P
submissions to the BE or CMC section of existing (prior to October 1,
2023) JINAD files).

B. Application Fee Rates for FY 2024

    FDA must set the fee rates for FY 2024 so that the estimated 15.80
abbreviated application fees and 60 JINAD file fees will generate a
total of $5,000,000. The fee for a new JINAD file request or the first
submission to an existing (prior to October 1, 2023) JINAD file is
$50,000 under section 741(c)(1)(C) of the FD&C Act. Therefore, the
JINAD fees will generate a total of $3,000,000. Abbreviated application
fees will have to generate a total of $2,000,000.
    To generate this amount, the fee for a generic new animal drug
application will have to be $126,582 and for those applications that
are subject to the criteria set forth in section 512(d)(4) of the FD&C
Act, 50 percent of that amount, or $63,291.

IV. Generic New Animal Drug Product Fee Calculations for FY 2024

A. Product Fee Revenues and Numbers of Fee-Paying Products

    The generic new animal drug product fee must be paid annually by
the person named as the applicant in an abbreviated application or
supplemental abbreviated application for a generic new animal drug
product submitted for listing under section 510 of the FD&C Act (21
U.S.C. 360), and who had an abbreviated application or supplemental
abbreviated application for a generic new animal drug product pending
at FDA after September 1, 2008 (see 21 U.S.C. 379j-21(a)(2)). The term
``generic new animal drug product'' means each specific strength or
potency of a particular active ingredient or ingredients in final
dosage form marketed by a particular manufacturer or distributor, which
is uniquely identified by the labeler code and product code portions of
the National Drug Code, and for which an abbreviated application for a
generic new animal drug or supplemental abbreviated application for a
generic new animal drug has been approved (21 U.S.C. 379j-21(k)(6)).
The product fees are to be set so that they will generate $10,000,000
in fee revenue for FY 2024.
    To set generic new animal drug product fees to realize $10,000,000,
FDA must make some assumptions about the number of products for which
these fees will be paid in FY 2024. FDA gathered data on all generic
new animal drug products that have been submitted for listing under
section 510 of the FD&C Act and matched this to the list of all persons
who FDA estimated would have a generic new animal drug application or
supplemental abbreviated application pending after September 1, 2008.
As of May 2023, FDA estimates that there is a total of 616 products
submitted for listing by persons who had an abbreviated application for
a generic new animal drug or supplemental abbreviated application for a
generic new animal drug pending after September 1, 2008. Based on this,
FDA believes that a total of 616 products will be subject to this fee
in FY 2024.
    In estimating the fee revenue to be generated by generic new animal
drug product fees in FY 2024, FDA is estimating that 1 percent of the
products invoiced, or 6 products, will qualify for minor use/minor
species fee waiver (see 21 U.S.C. 379j-21(d)). FDA has made this
estimate at 1 percent this year, based on historical data over the past
5 completed fiscal years of the AGDUFA program.
    Accordingly, the Agency estimates that a total of 610 (616 minus 6)
products will be subject to product fees in FY 2024.

B. Product Fee Rates for FY 2024

    FDA must set the fee rates for FY 2024 so that the estimated 610
products for which fees are paid will generate a total of $10,000,000.
To generate this amount will require the fee for a generic new animal
drug product, rounded to the nearest dollar, to be $16,393.

V. Generic New Animal Drug Sponsor Fee Calculations for FY 2024

A. Sponsor Fee Revenues and Numbers of Fee-Paying Sponsors

    The generic new animal drug sponsor fee must be paid annually by
each person who: (1) is named as the applicant in an abbreviated
application for a generic new animal drug, except for an approved
application for which all subject products have been removed from
listing under section 510 of the FD&C Act, or has submitted an
investigational submission for a generic new animal drug that has not
been terminated or otherwise rendered inactive and (2) had an
abbreviated application for a generic new animal drug, supplemental
abbreviated application for a generic new animal drug, or
investigational submission for a generic new animal drug pending at FDA
after September 1, 2008 (see 21 U.S.C. 379j-21(k)(7) and 379j-
21(a)(3)).
    A generic new animal drug sponsor is subject to only one such fee
each fiscal year (see 21 U.S.C. 379j-21(a)(3)(C)). Applicants with more
than 6 approved abbreviated applications will pay 100 percent of the
sponsor fee; applicants with more than 1 and fewer than 7 approved
abbreviated applications will pay 75 percent of the sponsor fee; and
applicants with 1 or fewer approved abbreviated applications will pay
50 percent of the sponsor fee (see 21 U.S.C. 379j-21(a)(3)(C)). The
sponsor fees are to be set so that they will generate $10,000,000 in
fee revenue for FY 2024.

    To set generic new animal drug sponsor fees to realize $10,000,000,
FDA must make some assumptions about the number of sponsors who will
pay these fees in FY 2024. FDA developed data on all generic new animal
drug sponsors and matched this to the list of all sponsors who had
pending submissions and applications after September 1, 2008. As of
May, 2023, FDA estimates that in FY 2024, 12 sponsors will pay 100
percent fees, 18 sponsors will pay 75 percent fees, and 28 sponsors
will pay 50 percent fees. The total of these figures is the equivalent
of 39.5 full sponsor fees (12 times 100 percent or 12, plus 18 times 75
percent or 13.5 plus 28 times 50 percent or 14).
    FDA estimates that about 2 percent of all of these sponsors, or
0.79, may qualify for a minor use/minor species fee waiver (see 21
U.S.C. 379j-21(d)). FDA has made the estimate of the percentage of
sponsors that will not pay fees at 2 percent this year, based on
historical data over the past 5 completed fiscal years of the AGDUFA
program.
    Accordingly, the Agency estimates that the equivalent of 38.71 full
sponsor fees (39.5 minus 0.79) are likely to be paid in FY 2024.

B. Sponsor Fee Rates for FY 2024

    FDA must set the fee rates for FY 2024 so that the estimated
equivalent of 38.71 full sponsor fees will generate a total of
$10,000,000. To generate this amount will require the 100 percent fee
for a generic new animal drug sponsor, rounded to the nearest dollar,
to be $258,331. Accordingly, the fee for those paying 75 percent of the
full sponsor fee will be $193,748, and the fee for those paying 50
percent of the full sponsor fee will be $129,166.

VI. Fee Schedule for FY 2024

    The fee rates for FY 2024 are summarized in table 1.

                       Table 1--FY 2024 Fee Rates
------------------------------------------------------------------------
                                                           Fee rate for
                    User fee category                         FY 2024
------------------------------------------------------------------------
Abbreviated Application Fee for Generic New Animal Drug         $126,582
 except those subject to the criteria in section
 512(d)(4) of the FD&C Act..............................
Abbreviated Application Fee for Generic New Animal Drug           63,291
 subject to the criteria in section 512(d)(4) of the
 FD&C Act...............................................
JINAD File Fee..........................................          50,000
Generic New Animal Drug Product Fee.....................         $16,393
100% Generic New Animal Drug Sponsor Fee \1\............         258,331
75% Generic New Animal Drug Sponsor Fee \1\.............         193,748
50% Generic New Animal Drug Sponsor Fee \1\.............         129,166
------------------------------------------------------------------------
\1\ An animal drug sponsor is subject to only one fee each fiscal year.

VII. Fee Waiver or Reduction; Exemption From Fees

    The types of fee waivers and reductions that applied last fiscal
year still exist for FY 2024 (see 21 U.S.C. 379j-21(d)(1)). However,
there is no longer an exemption for any person who submits to CVM a
supplemental abbreviated application relating to a generic new animal
drug approved under section 512 of the FD&C Act, solely to add the
application number to the labeling of the drug in the manner specified
in section 502(w)(3) of the FD&C Act (21 U.S.C. 352(w)(3)). This
exemption was added in AGDUFA III, but is not a part of AGDUFA IV.

VIII. Procedures for Paying FY 2024 Fees

A. Abbreviated Application Fees, JINAD File Fees, and Payment
Instructions

    The FY 2024 fees established in the new fee schedule must be paid
for the following applications/submissions that are subject to fees
under AGDUFA IV and submitted on or after October 1, 2023: a generic
new animal drug application, a submission requesting to establish a
JINAD file, or the first BE or CMC submission to a JINAD file that was
established prior to October 1, 2023. The payment must be made in U.S.
currency from a U.S. bank by one of the following methods: wire
transfer, electronically, check, bank draft, or U.S. postal money order
made payable to the Food and Drug Administration. The preferred payment
method is online using electronic check (Automated Clearing House
(ACH), also known as eCheck) or credit card (Discover, VISA,
MasterCard, American Express). Secure electronic payments can be
submitted using the User Fees Payment Portal at https://userfees.fda.gov/pay or the Pay.gov payment option is available to you
after you submit a cover sheet. (Note: only full payments are accepted.
No partial payments can be made online.) Once you find your invoice,
select ``Pay Now'' to be redirected to Pay.gov. Electronic payment
options are based on the balance due. Payment by credit card is
available only for balances that are less than $25,000. If the balance
exceeds this amount, only the ACH option is available. Payments must be
made using U.S. bank accounts as well as U.S. credit cards.
    When paying by check, bank draft, or U.S. postal money order,
please write your application's unique Payment Identification Number
(PIN), beginning with the letters ``AG'', on the upper right-hand
corner of your completed Animal Generic Drug User Fee Cover Sheet. Also
write FDA's post office box number (P.O. Box 979033) and PIN on the
enclosed check, bank draft, or money order. Mail the payment and a copy
of the completed Animal Generic Drug User Fee Cover Sheet to: Food and
Drug Administration, P.O. Box 979033, St. Louis, MO 63197-9000. Note:
In no case should the payment for the fee be submitted to FDA with the
application or JINAD file submission.
    When paying by wire transfer, the invoice number or PIN needs to be
included. Without the invoice number or PIN, the payment may not be
applied, and the invoice amount would be referred to collections. The
originating financial institution may charge a wire transfer fee. If
the financial institution charges a wire transfer fee, it is required
to add that amount to the payment to ensure that the invoice is paid in
full. Use the following account information when sending a payment by
wire transfer: U.S. Department of the Treasury, TREAS NYC, 33 Liberty
St., New York, NY 10045, Account Name: Food and Drug Administration,
Account Number: 75060099, U.S. Department of the Treasury routing/
transit number: 021030004, SWIFT Number: FRNYUS33.
    To send a check by a courier such as FedEx, the courier must
deliver the check and printed copy of the cover sheet to U.S. Bank:
U.S. Bank, Attn: Government Lockbox 979033, 3180

Rider Trail South, Earth City, MO 63045. (Note: This address is for
courier delivery only. If you have any questions concerning courier
delivery, contact U.S. Bank at<PHONE_NUMBER>. This telephone number is
only for questions about courier delivery.)
    It is important that the fee arrives at the bank at least a day or
two before the abbreviated application arrives at FDA's CVM. FDA
records the official abbreviated application receipt date as the later
of the following: the date the application was received by CVM, or the
date U.S. Bank notifies FDA that your payment in the full amount has
been received, or when the U.S. Department of the Treasury notifies FDA
of payment. U.S. Bank and the U.S. Department of the Treasury are
required to notify FDA within 1 working day, using the PIN described
previously.
    The tax identification number of FDA is 53-0196965.

B. Application and JINAD File Submission Cover Sheet Procedures

    Step One: Create a user account and password. Log onto the AGDUFA
website at https://www.fda.gov/ForIndustry/UserFees/AnimalGenericDrugUserFeeActAGDUFA/ucm137049.htm and, under Application
Submission Information, click on ``Create AGDUFA User Fee Cover Sheet''
and follow the directions. For security reasons, each firm submitting
an application and/or a JINAD file submission will be assigned an
organization identification number, and each user will also be required
to set up a user account and password the first time you use this site.
Online instructions will walk you through this process.
    Step Two: Create an Animal Generic Drug User Fee Cover Sheet,
transmit it to FDA, and print a copy. After logging into your account
with your username and password, complete the steps required to create
an Animal Generic Drug User Fee Cover Sheet. One cover sheet is needed
for each abbreviated application for a generic new animal drug or JINAD
file submission. Once you are satisfied that the data on the cover
sheet is accurate and you have finalized the cover sheet, you will be
able to transmit it electronically to FDA and you will be able to print
a copy of your cover sheet showing your unique PIN.
    Step Three: Send the payment for your application or JINAD file
submission as described in section VIII.A.
    Step Four: Submit your application or JINAD file submission.

C. Product and Sponsor Fees

    By December 31, 2023, FDA will issue invoices and payment
instructions for product and sponsor fees for FY 2024 using this fee
schedule. Payment will be due by January 31, 2024. FDA will issue
invoices in November 2024 for any products and sponsors subject to fees
for FY 2024 that qualify for fees after the December 2023 billing.

    Dated: October 18, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023-23374 Filed 10-20-23; 8:45 am]
BILLING CODE 4164-01-P


[Federal Register Volume 85, Number 20 (Thursday, January 30, 2020)]
[Notices]
[Page 5427]
[FR Doc No: 2020-01662]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OECA-2013-0314; FRL-10004-76-OMS]

Information Collection Request Submitted to OMB for Review and
Approval; Comment Request; NSPS for Phosphate Rock Plants (Renewal)

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Environmental Protection Agency (EPA) has submitted an
information collection request (ICR), NSPS for Phosphate Rock Plants
(EPA ICR Number 1078.12, OMB Control Number 2060-0111), to the Office
of Management and Budget (OMB) for review and approval in accordance
with the Paperwork Reduction Act. This is a proposed extension of the
ICR, which is currently approved through March 31, 2020. Public
comments were previously requested via the Federal Register on May 6,
2019 during a 60-day comment period. This notice allows for an
additional 30 days for public comments. A fuller description of the ICR
is given below, including its estimated burden and cost to the public.
An agency may neither conduct nor sponsor, and a person is not required
to respond to, a collection of information unless it displays a
currently valid OMB control number.

DATES: Additional comments may be submitted on or before March 2, 2020.

ADDRESSES: Submit your comments, referencing Docket ID Number EPA-HQ-
OECA-2013-0314, to: (1) EPA online using www.regulations.gov (our
preferred method), or by email to<EMAIL_ADDRESS>or by mail to:
EPA Docket Center, Environmental Protection Agency, Mail Code 28221T,
1200 Pennsylvania Ave. NW, Washington, DC 20460; and (2) OMB via email
to<EMAIL_ADDRESS>Address comments to OMB Desk Officer
for EPA.
    EPA's policy is that all comments received will be included in the
public docket without change, including any personal information
provided, unless the comment includes profanity, threats, information
claimed to be Confidential Business Information (CBI), or other
information whose disclosure is restricted by statute.

FOR FURTHER INFORMATION CONTACT: Patrick Yellin, Monitoring,
Assistance, and Media Programs Division, Office of Compliance, Mail
Code 2227A, Environmental Protection Agency, 1200 Pennsylvania Ave. NW,
Washington, DC 20460; telephone number:<PHONE_NUMBER>; fax number:
(202) 564-0050; email address<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: Supporting documents, which explain in
detail the information that the EPA will be collecting, are available
in the public docket for this ICR. The docket can be viewed online at
www.regulations.gov, or in person, at the EPA Docket Center, WJC West,
Room 3334, 1301 Constitution Ave. NW, Washington, DC. The telephone
number for the Docket Center is<PHONE_NUMBER>. For additional
information about EPA's public docket, visit: http://www.epa.gov/dockets.
    Abstract: The New Source Performance Standards (NSPS) for Phosphate
Rock Plants (40 CFR part 60, subpart NN) apply to the following
existing facilities and new facilities at phosphate rock plants with
capacities greater than 4 tons per hour: Dryers, calciners, grinders,
and ground rock handling and storage facilities, except those
facilities producing or preparing phosphate rock solely for consumption
in elemental phosphorus production. New facilities include those that
commenced construction, modification or reconstruction after the date
of proposal. This information is being collected to assure compliance
with 40 CFR part 60, subpart NN. In general, all NSPS standards require
initial notifications, performance tests, and periodic reports by the
owners/operators of the affected facilities. They are also required to
maintain records of the occurrence and duration of any startup,
shutdown, or malfunction in the operation of an affected facility, or
any period during which the monitoring system is inoperative. These
notifications, reports, and records are essential in determining
compliance, and are required of all affected facilities subject to
NSPS.
    Form Numbers: None.
    Respondents/affected entities: Owners and operators of phosphate
rock plants.
    Respondent's obligation to respond: Mandatory (40 CFR part 60,
subpart NN).
    Estimated number of respondents: 15 (total).
    Frequency of response: Initially and semiannually.
    Total estimated burden: 1,800 hours (per year). Burden is defined
at 5 CFR 1320.3(b).
    Total estimated cost: $335,000 (per year), which includes $126,000
in annualized capital/startup and/or operation & maintenance costs.
    Changes in the Estimates: There is an adjustment decrease in the
total estimated burden in this ICR as currently identified in the OMB
Inventory of Approved Burdens. This increase is not due to any program
changes. The adjustment decrease in burden from the most-recently
approved ICR is due to a decrease in the number of sources. The growth
rate for the industry is very low, negative or non-existent, so the ICR
has been adjusted to account for no new respondents over the next three
years. This also results in a reduction in capital/startup costs.

Courtney Kerwin,
Director, Regulatory Support Division.
[FR Doc. 2020-01662 Filed 1-29-20; 8:45 am]
 BILLING CODE 6560-50-P


[Federal Register: December 22, 2006 (Volume 71, Number 246)]
[Notices]
[Page 77014-77015]
[DOCID:fr22de06-65]

-----------------------------------------------------------------------

 ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPP-2006-0847; FRL-8102-8]

Colorado State Plan for Certification of Applicators of
Restricted Use Pesticides; Notice of Availability

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice of intent to approve, on a contingent basis.

-----------------------------------------------------------------------

SUMMARY:  The State of Colorado has submitted to EPA several statutory,
regulatory, and programmatic amendments to its State Plan for
Certification and Training of Applicators of Restricted Use Pesticides
(RUPs). The amended State Plan provides details for the certification
of both private and commercial pesticide applicators and subsequent
enforcement of pesticide laws and regulations pursuant to the Colorado
Pesticide Applicators' Act. EPA is currently responsible for certifying
private applicators of RUPs in Colorado, while the Colorado Department
of Agriculture is responsible for certifying commercial applicators of
RUPs. EPA approval of Colorado's amended State Plan will allow Colorado
to assume regulatory authority for certification of both private and
commercial applicators of RUPs. In addition, the amended State Plan
adds three new commercial pesticide applicator subcategories: Metam-
sodium for sewer root control; wood preservation and wood products
treatment; and interior plant pest control. Notice is hereby given of
the intention of the Regional Administrator, Region VIII, to approve
the revised Plan for the Certification of Applicators of Restricted Use
Pesticides on a contingency basis, as provided at 40 CFR
171.7(b)(1)(ii). Approval of the amended State Plan is contingent upon
the promulgation of revised State Rules and Regulations pertaining to
the Administration and Enforcement of the Colorado Pesticide
Applicators' Act on January 1, 2007. EPA is soliciting comments on the
proposed amendments.

DATES: Comments must be received on or before January 22, 2007.

ADDRESSES: Submit your comments, identified by docket identification
(ID) number EPA-HQ-OPP-2006-0847, by one of the following methods:
     Federal eRulemaking Portal: http://www.regulations.gov.

Follow the on-line instructions for submitting comments.
     Mail: Office of Pesticide Programs (OPP) Regulatory Public
Docket (7502P), Environmental Protection Agency, 1200 Pennsylvania
Ave., NW., Washington, DC 20460-0001.
     Delivery: OPP Regulatory Public Docket (7502P),
Environmental Protection Agency, Rm. S-4400, One Potomac Yard (South
Building), 2777 S. Crystal Drive, Arlington, VA. Deliveries are only
accepted during the Docket's normal hours of operation (8:30 a.m. to 4
p.m., Monday through Friday, excluding legal holidays). Special
arrangements should be made for deliveries of boxed information. The
Docket telephone number is<PHONE_NUMBER>.
    Instructions: Direct your comments to docket ID number EPA-HQ-OPP-
2006-0847. EPA's policy is that all comments received will be included
in the docket without change and may be made available online at http://www.regulations.gov
, including any personal information provided,

unless the comment includes information claimed to be Confidential
Business Information (CBI) or other information whose disclosure is
restricted by statute. Do not submit information that you consider to
be CBI or otherwise protected through regulations.gov or e-mail. The
Federal regulations.gov website is an ``anonymous access'' system,
which means EPA will not know your identity or contact information
unless you provide it in the body of your comment. If you send an e-
mail comment directly to EPA without going through regulations.gov,
your e-mail address will be automatically captured and included as part
of the comment that is placed in the docket and made available on the
Internet. If you submit an electronic comment, EPA recommends that you
include your name and other contact information in the body of your
comment and with any disk or CD-ROM you submit. If EPA cannot read your
comment due to technical difficulties and cannot contact you for
clarification, EPA may not be able to consider your comment. Electronic
files should avoid the use of special characters, any form of
encryption, and be free of any defects or viruses.
    Docket: All documents in the docket are listed in the docket index.
Although listed in the index, some information is not publicly
available e.g., CBI or other information whose disclosure is restricted
by statute. Certain other material, such as copyrighted material, is
not placed on the Internet and will be publicly available only in hard
copy form. Publicly available docket materials are available either in
the electronic docket athttp://www.regulations.gov, or, if only

available in hard copy, at the OPP Regulatory Public Docket in Rm. S-
4400, One Potomac Yard (South Building), 2777 S. Crystal Drive,
Arlington, VA. The hours of operation of this Docket Facility are from
8:30 a.m. to 4 p.m., Monday through Friday, excluding legal holidays.
The Docket telephone number is<PHONE_NUMBER>.

FOR FURTHER INFORMATION CONTACT:  Peg Perreault, Pollution Prevention,
Pesticides, and Toxics Program (8P-P3T), 999 18th St., Suite 200,
Denver, CO 80202-2466; telephone number:

(303) 312-6286; e-mail address<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this Action Apply to Me?

    This action is directed to the public in general. This action may,
however, be of interest to those involved in agriculture and anyone
involved with the distribution and application of pesticides for
agricultural purposes. Others involved with pesticides in a non-
agricultural setting may also be affected. In addition, it may be of
interest to others, such as, those persons who are or may be required
to conduct testing of chemical substances under the Federal Food, Drug,
and Cosmetic Act (FFDCA), or the Federal Insecticide, Fungicide, and
Rodenticide Act (FIFRA). Since other entities may also be interested,
the Agency has not attempted to describe all the specific entities that
may be affected by this action. If you have any questions regarding the
applicability of this action to a particular entity, consult the person
listed under FOR FURTHER INFORMATION CONTACT.

B. What Should I Consider as I Prepare My Comments for EPA?

    1. Submitting CBI. Do not submit this information to EPA through
regulations.gov or e-mail. Clearly mark the part or all of the
information that you claim to be CBI. For CBI information in a disk or
CD ROM that you mail to EPA, mark the outside of the disk or CD ROM as
CBI and then identify electronically within the disk or CD ROM the
specific information that is claimed as CBI. In addition to one
complete version of the comment that includes information claimed as
CBI, a copy of the comment that does not contain the information
claimed as CBI must be submitted for inclusion in the public docket.
Information so marked will not be disclosed except in accordance with
procedures set forth in 40 CFR part 2.
    2. Tips for preparing your comments. When submitting comments,
remember to:
    i. Identify the document by docket ID number and other identifying
information (subject heading, Federal Register date and page number).
    ii. Follow directions. The Agency may ask you to respond to
specific questions or organize comments by referencing a Code of
Federal Regulations (CFR) part or section number.
    iii. Explain why you agree or disagree; suggest alternatives and
substitute language for your requested changes.
    iv. Describe any assumptions and provide any technical information
and/or data that you used.
    v. If you estimate potential costs or burdens, explain how you
arrived at your estimate in sufficient detail to allow for it to be
reproduced.
    vi. Provide specific examples to illustrate your concerns and
suggest alternatives.
    vii. Explain your views as clearly as possible, avoiding the use of
profanity or personal threats.
    viii. Make sure to submit your comments by the comment period
deadline identified. In addition to the sources listed in this unit,
you may obtain copies of the amended Colorado Certification Plan, other
related documents, or additional information by contacting:
    1. Peg Perreault at the address listed under FOR FURTHER
INFORMATION CONTACT.
    2. John Scott, Colorado Department of Agriculture, 700 Kipling St.,
Suite 4000, Lakewood, CO 80215; telephone number:<PHONE_NUMBER>; e-
mail address<EMAIL_ADDRESS>    3. Richard Pont, Field and External Affairs Division (7506C),
Office of Pesticide Programs, Environmental Protection Agency, 1200
Pennsylvania Ave., NW., Washington, DC 20460-0001; telephone number:
(703) 305-6448; e-mail address<EMAIL_ADDRESS>
 II. What Action is the Agency Taking?

    EPA has reviewed the revised Colorado Certification Plan and has
determined that it complies with FIFRA and its implementing regulations
at 40 CFR part 171. Accordingly, the Agency is announcing its intent to
approve the amended State Plan on a contingency basis pending
promulgation of revised Colorado Rules and Regulations Pertaining to
the Administration and Enforcement of the Colorado Pesticide
Applicators' Act on January 1, 2007, and is seeking public comment.

List of Subjects

    Environmental protection, Education, Pests and pesticides.

    Dated: December 5, 2006.

Robert E. Roberts,
Regional Administrator, Region VIII.
[FR Doc. E6-21973 Filed 12-21-06; 8:45 am]

BILLING CODE 6560-50-S


[Federal Register: September 18, 2006 (Volume 71, Number 180)]
[Notices]
[Page 54635]
[DOCID:fr18se06-43]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. CP06-446-000]

Gulf South Pipeline Company, LP; Notice of Application

September 11, 2006.
    Take notice that on September 1, 2006, Gulf South Pipeline Company,
LP (Gulf South), 20 East Greenway Plaza, Houston, Texas 77046, filed in
Docket No. CP06-446-000, an application pursuant to sections 7(b) and
7(c) of the Natural Gas Act (NGA) to authorize Gulf South to site,
construct, and operate facilities consisting of 241.9 miles of
pipeline, 110,604 horsepower of compression, interconnecting facilities
and appurtenant facilities, and to abandon by lease to Texas Gas
Transmission, LLC (Texas Gas), 62,180 Dth/day of capacity on the
facilities proposed herein, all as more fully set forth in the
application which is on file with the Commission and open to public
inspection. In a related application, Texas Gas filed in Docket No.
CP06-441-000, for authorization to lease the capacity under section 7
of the NGA. The instant filing may be also viewed on the web at http://www.ferc.gov
 using the ``eLibrary'' link. Enter the docket number

excluding the last three digits in the docket number field to access
the document. For assistance, call<PHONE_NUMBER> or TTY, (202) 502-
8659.
    Any questions regarding this application may be directed to J. Kyle
Stephens, Director of Certificates, 20 East Greenway Plaza, Houston,
Texas 77046 or by telephone at<PHONE_NUMBER> or telecopy to 713-544-
3540.
    On February 17, 2006, the Commission staff granted Gulf South's
request to utilize the Commission's Pre-Filing Process for its East
Texas Expansion Project and assigned Docket No. PF06-17-000 to staff
activities involving the East Texas Expansion Project. Additionally, on
April 13, 2006, the Commission staff granted Gulf South's request to
utilize the Commission's Pre-Filing Process for its Mississippi
Expansion Project and assigned Docket No. PF06-23-000 to that project.
Now, as of the filing of Gulf South's application on September 1, 2006,
the Commission's Pre-Filing Process for these projects has ended. As
Gulf South's two expansion projects have now been combined into one
project, from this time forward, Gulf South's proceeding will be
conducted in Docket No. CP06-446-000, as noted in the caption of this
Notice.
    There are two ways to become involved in the Commission's review of
this project. First, any person wishing to obtain legal status by
becoming a party to the proceedings for this project should, on or
before the below listed comment date, file with the Federal Energy
Regulatory Commission, 888 First Street, NE., Washington, DC 20426, a
motion to intervene in accordance with the requirements of the
Commission's Rules of Practice and Procedure (18 CFR 385.214 or
385.211) and the Regulations under the NGA (18 CFR 157.10). A person
obtaining party status will be placed on the service list maintained by
the Secretary of the Commission and will receive copies of all
documents filed by the applicant and by all other parties. A party must
submit 14 copies of filings made with the Commission and must mail a
copy to the applicant and to every other party in the proceeding. Only
parties to the proceeding can ask for court review of Commission orders
in the proceeding.
    However, a person does not have to intervene in order to have
comments considered. The second way to participate is by filing with
the Secretary of the Commission, as soon as possible, an original and
two copies of comments in support of or in opposition to this project.
The Commission will consider these comments in determining the
appropriate action to be taken, but the filing of a comment alone will
not serve to make the filer a party to the proceeding. The Commission's
rules require that persons filing comments in opposition to the project
provide copies of their protests only to the party or parties directly
involved in the protest.
    Persons who wish to comment only on the environmental review of
this project should submit an original and two copies of their comments
to the Secretary of the Commission. Environmental commenters will be
placed on the Commission's environmental mailing list, will receive
copies of the environmental documents, and will be notified of meetings
associated with the Commission's environmental review process.
Environmental commenters will not be required to serve copies of filed
documents on all other parties. However, the non-party commenters will
not receive copies of all documents filed by other parties or issued by
the Commission (except for the mailing of environmental documents
issued by the Commission) and will not have the right to seek court
review of the Commission's final order.
    Motions to intervene, protests and comments may be filed
electronically via the Internet in lieu of paper; see, 18 CFR
385.2001(a)(1)(iii) and the instructions on the Commission's Web site
under the ``e-Filing'' link. The Commission strongly encourages
electronic filings.
    Comment Date: October 2, 2006.

Magalie R. Salas,
Secretary.
[FR Doc. E6-15390 Filed 9-15-06; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register Volume 87, Number 43 (Friday, March 4, 2022)]
[Notices]
[Page 12478]
[FR Doc No: 2022-04586]

-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Federal Emergency Management Agency

[Internal Agency Docket No. FEMA-4629-DR; Docket ID FEMA-2022-0001]

Connecticut; Amendment No. 2 to Notice of a Major Disaster
Declaration

AGENCY: Federal Emergency Management Agency, DHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice amends the notice of a major disaster declaration
for the State of Connecticut (FEMA-4629-DR), dated October 30, 2021,
and related determinations.

DATES: This amendment was issued February 2, 2022.

FOR FURTHER INFORMATION CONTACT: Dean Webster, Office of Response and
Recovery, Federal Emergency Management Agency, 500 C Street SW,
Washington, DC 20472,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: The notice of a major disaster declaration
for the State of Connecticut is hereby amended to include the Public
Assistance program for the following areas among those areas determined
to have been adversely affected by the event declared a major disaster
by the President in his declaration of October 30, 2021.

    Fairfield and Litchfield Counties for Public Assistance.
    The following Catalog of Federal Domestic Assistance Numbers
(CFDA) are to be used for reporting and drawing funds: 97.030,
Community Disaster Loans; 97.031, Cora Brown Fund; 97.032, Crisis
Counseling; 97.033, Disaster Legal Services; 97.034, Disaster
Unemployment Assistance (DUA); 97.046, Fire Management Assistance
Grant; 97.048, Disaster Housing Assistance to Individuals and
Households in Presidentially Declared Disaster Areas; 97.049,
Presidentially Declared Disaster Assistance--Disaster Housing
Operations for Individuals and Households; 97.050, Presidentially
Declared Disaster Assistance to Individuals and Households--Other
Needs; 97.036, Disaster Grants--Public Assistance (Presidentially
Declared Disasters); 97.039, Hazard Mitigation Grant.

Deanne Criswell,
Administrator, Federal Emergency Management Agency.
[FR Doc. 2022-04586 Filed 3-3-22; 8:45 am]
BILLING CODE 9111-23-P


[Federal Register Volume 79, Number 189 (Tuesday, September 30, 2014)]
[Notices]
[Page 58773]
[FR Doc No: 2014-23219]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No. 14623-000]

Advanced Hydropower, Inc.; Notice of Preliminary Permit
Application Accepted for Filing and Soliciting Comments, Motions To
Intervene, and Competing Applications

    On May 6, 2014, Advanced Hydropower, Inc. filed an application for
a preliminary permit, pursuant to section 4(f) of the Federal Power Act
(FPA), proposing to study the feasibility of a hydropower project to be
located on the Cullasaja River, on lands within the Nantahala National
Forest, near the town of Highlands, in Macon County, North Carolina.
The sole purpose of a preliminary permit, if issued, is to grant the
permit holder priority to file a license application during the permit
term. A preliminary permit does not authorize the permit holder to
perform any land-disturbing activities or otherwise enter upon lands or
waters owned by others without the owners' express permission.
    The proposed project would consist of the following: (1) A 50-foot-
wide, 2-foot-high concrete diversion weir; (2) a 50-foot-wide, 2-foot-
high coanda effect screened intake structure; (3) a 2,000-foot-long,
36-inch-diameter above ground penstock; (4) a 30-foot-high, 25-foot-
long powerhouse containing one crossflow generating unit with a total
capacity of 775 kilowatts; (5) a 40-foot-long, 40-foot-wide tailrace;
(6) a 60-foot-long, 12.47 kilo-Volt transmission line. The project
would have an estimated average annual generation of 3,300 megawatt-
hours.
    Applicant Contact: Mr. Colin M. Gaines, Advanced Hydropower, Inc.,
3774 Chessa Lane, Clovis, CA 93619.<PHONE_NUMBER>.
    FERC Contact: Christiane Casey<EMAIL_ADDRESS>(202)
502-8577.
    Deadline for filing comments, motions to intervene, competing
applications (without notices of intent), or notices of intent to file
competing applications: 60 days from the issuance of this notice.
Competing applications and notices of intent must meet the requirements
of 18 CFR 4.36. Comments, motions to intervene, notices of intent, and
competing applications may be filed electronically via the Internet.
See 18 CFR 385.2001(a)(1)(iii) and the instructions on the Commission's
Web site http://www.ferc.gov/docs-filing/efiling.asp. Commenters can
submit brief comments up to 6,000 characters, without prior
registration, using the eComment system at http://www.ferc.gov/docs-filing/ecomment.asp. You must include your name and contact information
at the end of your comments. For assistance, please contact FERC Online
Support at<EMAIL_ADDRESS>or toll free at 1-866-208-3676,
or for TTY,<PHONE_NUMBER>. Although the Commission strongly encourages
electronic filing, documents may also be paper-filed. To paper-file,
mail an original and five copies to: Kimberly D. Bose, Secretary,
Federal Energy Regulatory Commission, 888 First Street NE., Washington,
DC 20426.
    More information about this project, including a copy of the
application, can be viewed or printed on the ``eLibrary'' link of
Commission's Web site at http://www.ferc.gov/docs-filing/elibrary.asp.
Enter the docket number (P-14623) in the docket number field to access
the document. For assistance, contact FERC Online Support.

    Dated: September 22, 2014.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2014-23219 Filed 9-29-14; 8:45 am]
BILLING CODE 6717-01-P